Chengde X. Yang

Number 197 Ruijin Second Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Single-cell sequencing in systemic lupus erythematosus.

Single-cell sequencing in systemic lupus erythematosus.

Journal: Lupus

Published: June 03, 2026

Deciphering Platelet Transcriptomic Profiles in Antiphospholipid Syndrome: Insights into Their Role as Immunological Players.

Deciphering Platelet Transcriptomic Profiles in Antiphospholipid Syndrome: Insights into Their Role as Immunological Players.

Journal: International journal of molecular sciences

Published: May 10, 2026

Lung disease in adult-onset Still's disease: a chinese cohort study.

Lung disease in adult-onset Still's disease: a chinese cohort study.

Journal: Rheumatology (Oxford, England)

Published: February 22, 2026

Long-term clinical outcomes and safety of rituximab in refractory neuropsychiatric systemic lupus erythematosus: a real-world single-center study.

Long-term clinical outcomes and safety of rituximab in refractory neuropsychiatric systemic lupus erythematosus: a real-world single-center study.

Journal: Clinical rheumatology

Published: January 27, 2026

Energy metabolism dysregulation in idiopathic inflammatory myopathies: mechanisms and therapeutic implications.

Energy metabolism dysregulation in idiopathic inflammatory myopathies: mechanisms and therapeutic implications.

Journal: Frontiers in immunology

Published: January 05, 2026

Pathological analysis of 1 712 cholecystectomy specimens for benign gallbladder diseases

Pathological analysis of 1 712 cholecystectomy specimens for benign gallbladder diseases

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: November 26, 2025

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease-Like Autoinflammatory Syndrome.

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease-Like Autoinflammatory Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 12, 2025

Benefits of adjunct plasma exchange in idiopathic inflammatory myopathy with anti-signal recognition particle antibodies：a real-world study.

Benefits of adjunct plasma exchange in idiopathic inflammatory myopathy with anti-signal recognition particle antibodies：a real-world study.

Journal: Rheumatology (Oxford, England)

Published: September 20, 2025

Development of a predictive tool for hemophagocytic lymphohistiocytosis/macrophage activation syndrome risk in adult-onset Still's disease.

Development of a predictive tool for hemophagocytic lymphohistiocytosis/macrophage activation syndrome risk in adult-onset Still's disease.

Journal: Frontiers in immunology

Published: September 19, 2025

Landscape of Somatic Mutations in a Large Cohort of Chinese Patients With Immune Dysregulations.

Landscape of Somatic Mutations in a Large Cohort of Chinese Patients With Immune Dysregulations.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 18, 2025

Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated Signaling.

Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated Signaling.

Journal: Circulation

Published: August 29, 2025

Identification of a metabolic-immune crosstalk in Still's disease: monocyte/macrophage-derived immunometabolite itaconate dictates hepatic immunopathology via the CXCL10-CD8 T cell axis.

Identification of a metabolic-immune crosstalk in Still's disease: monocyte/macrophage-derived immunometabolite itaconate dictates hepatic immunopathology via the CXCL10-CD8 T cell axis.

Journal: Experimental & molecular medicine

Published: August 21, 2025

Showing 1-12 of 104

Last Updated: 09/26/2026